These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 12077886)
1. [Pharmaceutical industry and clinical drug research]. Huttunen MO Duodecim; 2000; 116(24):2813-5. PubMed ID: 12077886 [No Abstract] [Full Text] [Related]
2. [The roles and responsibilities of the pharmaceutical industry]. Dejgaard A; Thomsen MK Ugeskr Laeger; 2003 Apr; 165(16):1676-9. PubMed ID: 12756829 [TBL] [Abstract][Full Text] [Related]
3. Industry-sponsored pharmaceutical trials and research ethics boards: are they cloaked in too much secrecy? Ferris LE CMAJ; 2002 May; 166(10):1279-80. PubMed ID: 12041844 [No Abstract] [Full Text] [Related]
4. Guinea-pigging: healthy human subjects for drug safety trials are in demand. But is it a living? Elliott C New Yorker; 2008 Jan; ():36-41. PubMed ID: 18265451 [No Abstract] [Full Text] [Related]
5. The right to a trial: Should dying patients have access to experimental drugs? Groopman J New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539 [No Abstract] [Full Text] [Related]
7. [Clinical drug research in Denmark--as effective, harmless and cheap as possible]. Højgaard L Ugeskr Laeger; 1994 Feb; 156(6):784-6. PubMed ID: 8016979 [No Abstract] [Full Text] [Related]
8. [Drug development costs are overstated by the industry]. Jeppsson A Lakartidningen; 2006 Mar 1-7; 103(9):663-4; discussion 664. PubMed ID: 16583545 [No Abstract] [Full Text] [Related]
9. European researchers up in arms over new clinical trials edict. Bosch X Nat Med; 2003 Nov; 9(11):1336. PubMed ID: 14595413 [No Abstract] [Full Text] [Related]
10. [Clinical research and pharmaceutical industry. A relationship with advantages and disadvantages]. ten Cate JW; Büller HR Ned Tijdschr Geneeskd; 1999 Jul; 143(30):1572-6. PubMed ID: 10443284 [TBL] [Abstract][Full Text] [Related]
11. Reporting clinical trials: full access to all the data. Author's right to access to all data obtained in their study. Rosenberg RN; Aminoff M; Boller F; Soerensen PS; Griggs RC; Hachinski V; Hallett M; Johnson RT; Kennard C; Lang AE; Lees AJ; Lisak R; Newsom-Davis J; Pedley TA; Selzer ME; Zochodne D J Neurol; 2002 May; 249(5):638-9. PubMed ID: 12021961 [No Abstract] [Full Text] [Related]
12. Industry money skews drug overviews. Giles J Nature; 2005 Sep; 437(7058):458-9. PubMed ID: 16177748 [No Abstract] [Full Text] [Related]
13. The quiet rise of the clinical contractor. Wadman M Nature; 2006 May; 441(7089):22-3. PubMed ID: 16672945 [No Abstract] [Full Text] [Related]
14. Data availability for industry sponsored trials: what should medical journals require? Steinbrook R; Kassirer JP BMJ; 2010 Oct; 341():c5391. PubMed ID: 20940213 [No Abstract] [Full Text] [Related]
15. Clinical quality assurance in the pharmaceutical industry. Donahue JJ Cancer Treat Rep; 1985 Oct; 69(10):1195-7. PubMed ID: 4042098 [No Abstract] [Full Text] [Related]
16. India's drug tests. Padma TV Nature; 2005 Jul; 436(7050):485. PubMed ID: 16049471 [No Abstract] [Full Text] [Related]
17. The pharmaceutical company and the academic medical center: win-win or mutual exploitation? Legato MJ J Gend Specif Med; 2002; 5(1):7-9. PubMed ID: 11859688 [No Abstract] [Full Text] [Related]
18. Conflicts of interest in data monitoring of industry versus publicly financed clinical trials. Lachin JM Stat Med; 2004 May; 23(10):1519-21. PubMed ID: 15122730 [TBL] [Abstract][Full Text] [Related]
19. Profit at a cost? Nat Cell Biol; 2000 Jul; 2(7):E113. PubMed ID: 10878816 [No Abstract] [Full Text] [Related]
20. [Dishonesty in clinical trials is expensive for the society 3]. Waldorff S Ugeskr Laeger; 2003 Jun; 165(26):2672-3; author reply 2673-4. PubMed ID: 12886557 [No Abstract] [Full Text] [Related] [Next] [New Search]